Michael J. Absalon, MD, PhD

Director, Medical Education Program

Associate Director, Leukemia/Lymphoma Program

Academic Affiliations

Assistant Professor, UC Department of Pediatrics

Phone 513-636-8790

Fax 513-636-3549

Email michael.absalon@cchmc.org


Relapsed leukemia; lymphoma


New therapeutics; ataxia telangiectasia; DNA damage response mechanisms

BS: Lewis and Clark College, Portland, OR, 1987.

PhD: Massachusetts Institute of Technology, Cambridge, MA, 1994.

MD: Oregon Health Sciences University, Portland, OR, 1998.

Fellowship: St. Jude Children's Research Hospital, Memphis, TN, 2005.

View PubMed Publications

Absalon MJ, Smith FO. Treatment strategies for pediatric acute myeloid leukemia. Expert Opin Pharmacother. 2009 Jan;10(1):57-79.

Absalon MJ, McCarville MB, Liu T, Santana VM, Daw NC, Navid F. Pulmonary nodules discovered during the initial evaluation of pediatric patients with bone and soft-tissue sarcoma. Pediatr Blood Cancer. 2008 Jun;50(6):1147-53.

Takagi M, Absalon MJ, McLure KG, Kastan MB. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell. 2005 Oct 7;123(1):49-63.

Absalon MJ, Harding CO, Fain DR, Li L, Mack KJ. Leigh syndrome in an infant due to mitochondrial DNA depletion. Pediatr Neurology. 2001; 24:60-63.